Income Taxes - Narrative (Details) - USD ($) $ in Thousands |
12 Months Ended | |
---|---|---|
Dec. 31, 2022 |
Dec. 31, 2021 |
|
Operating Loss Carryforwards [Line Items] | ||
Loss on discontinued operations | $ 9,976 | $ 0 |
Net operating losses | 65,905 | 51,580 |
R&D credits | 9,013 | 6,672 |
Net operating losses limited under Section 382 | 3,200 | |
Less valuation allowance | (118,040) | (65,134) |
Change in the valuation allowance | 52,906 | |
Federal | ||
Operating Loss Carryforwards [Line Items] | ||
Net operating losses | 276,638 | 223,961 |
Federal net operating losses with expiration | 24,429 | |
Federal net operating losses with no expiration | 252,209 | |
State | ||
Operating Loss Carryforwards [Line Items] | ||
Net operating losses | 156,501 | 106,644 |
Foreign | ||
Operating Loss Carryforwards [Line Items] | ||
Net operating losses | $ 408 | $ 1,383 |
X | ||||||||||
- Definition Deferred Tax Assets, Operating Loss Carryforwards, Subject to Limitation No definition available.
|
X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from the parent entity's basis in a discontinued operation. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates. No definition available.
|
X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates. No definition available.
|
X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|